Company:  CARDAX, INC. (CDXI)
Form Type:  10-Q
Filing Date:  11/14/2017 
CIK:  0001544238 
Address:  2800 WOODLAWN DRIVE
SUITE 129
 
City, State, Zip:  HONOLULU, Hawaii 96822 
Telephone:  808-457-1400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.37  
Change: 
0.00 (0.00%)  
Trade Time: 
Nov 21  
Market Cap: 
$45.25M
Trade CDXI now with 

© 2017  
Description of Business
Unless otherwise noted, references in this Annual Report on Form 10-K to "Cardax," the "Company," "we," "our," or "us" means Cardax, Inc., the registrant, and, unless the context otherwise requires, together with its wholly-owned subsidiary, Cardax Pharma, Inc., a Delaware corporation ("Pharma"), and Pharma's predecessor, Cardax Pharmaceuticals, Inc., a Delaware corporation ("Holdings"), which merged with and into Cardax, Inc. on December 30, 2015. Special Note Regarding Forward-Looking Statements There are statements in this annual report that are not historical facts. These "forward-looking statements" can be identified by use of terminology such as "anticipate," "believe," "estimate," "expect," "hope," "intend," "may," "plan," "positioned," "project," "propose," "should," "strategy," "will," or any similar expressions. You should be aware that these forward-looking statements are subject to risks and uncertainties that are beyond our control.
Register and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      Item 1. Financial Statements.
        BALANCE SHEET
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        NOTE 14 - SUBSEQUENT EVENTS
      Item 2. Management's Discussion and Analysis of Financial ...
      FINANCIAL STATEMENTS
        CASH FLOW
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures.
    PART II. OTHER INFORMATION
      Item 1. Legal Proceedings.
      Item 1A. Risk Factors.
      Item 2. Unregistered Sales of Equity Securities and Use of ...
      Item 3. Defaults Upon Senior Securities.
      Item 4. Mine Safety Disclosures.
      Item 5. Other Information.
      Item 6. Exhibits.
    SIGNATURES
  EXHIBIT 10.2
  EXHIBIT 31.1
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
  EXHIBIT 31.2
    CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
  EXHIBIT 32.1
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
  EXHIBIT 32.2
    CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO